These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 32738435)

  • 21. Systematic workflow for studying domain contributions of bispecific antibodies to selectivity in multimodal chromatography.
    Parasnavis SS; Niu B; Aspelund M; Chung WK; Snyder M; Cramer SM
    Biotechnol Bioeng; 2022 Jan; 119(1):211-225. PubMed ID: 34687215
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Single variable domain-IgG fusion. A novel recombinant approach to Fc domain-containing bispecific antibodies.
    Shen J; Vil MD; Jimenez X; Iacolina M; Zhang H; Zhu Z
    J Biol Chem; 2006 Apr; 281(16):10706-14. PubMed ID: 16481314
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Production of bispecific antibodies in "knobs-into-holes" using a cell-free expression system.
    Xu Y; Lee J; Tran C; Heibeck TH; Wang WD; Yang J; Stafford RL; Steiner AR; Sato AK; Hallam TJ; Yin G
    MAbs; 2015; 7(1):231-42. PubMed ID: 25427258
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ion Mobility-Mass Spectrometry and Collision-Induced Unfolding of Designed Bispecific Antibody Therapeutics.
    Villafuerte-Vega RC; Li HW; Slaney TR; Chennamsetty N; Chen G; Tao L; Ruotolo BT
    Anal Chem; 2023 May; 95(17):6962-6970. PubMed ID: 37067470
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Excellent removal of knob-into-hole bispecific antibody byproducts and impurities in a single-capture chromatography.
    Chen SW; Hoi KM; Mahfut FB; Yang Y; Zhang W
    Bioresour Bioprocess; 2022 Jul; 9(1):72. PubMed ID: 38647639
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sheathless CE-MS as a tool for monitoring exchange efficiency and stability of bispecific antibodies.
    Gstöttner C; Vergoossen DLE; Wuhrer M; Huijbers MGM; Domínguez-Vega E
    Electrophoresis; 2021 Jan; 42(1-2):171-176. PubMed ID: 32901958
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fab-based bispecific antibody formats with robust biophysical properties and biological activity.
    Wu X; Sereno AJ; Huang F; Lewis SM; Lieu RL; Weldon C; Torres C; Fine C; Batt MA; Fitchett JR; Glasebrook AL; Kuhlman B; Demarest SJ
    MAbs; 2015; 7(3):470-82. PubMed ID: 25774965
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Development of a novel affinity chromatography resin for platform purification of bispecific antibodies with modified protein a binding avidity.
    Tustian AD; Laurin L; Ihre H; Tran T; Stairs R; Bak H
    Biotechnol Prog; 2018 May; 34(3):650-658. PubMed ID: 29464924
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparing the relative robustness of byproduct removal by wash and by elution in column chromatography for the purification of a bispecific antibody.
    Wan Y; Zhang T; Wang Y; Li Y
    Protein Expr Purif; 2021 Jan; 177():105762. PubMed ID: 32971297
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Computational design of a specific heavy chain/κ light chain interface for expressing fully IgG bispecific antibodies.
    Froning KJ; Leaver-Fay A; Wu X; Phan S; Gao L; Huang F; Pustilnik A; Bacica M; Houlihan K; Chai Q; Fitchett JR; Hendle J; Kuhlman B; Demarest SJ
    Protein Sci; 2017 Oct; 26(10):2021-2038. PubMed ID: 28726352
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Coupling Mixed-Mode Size Exclusion Chromatography with Native Mass Spectrometry for Sensitive Detection and Quantitation of Homodimer Impurities in Bispecific IgG.
    Yan Y; Xing T; Wang S; Daly TJ; Li N
    Anal Chem; 2019 Sep; 91(17):11417-11424. PubMed ID: 31373790
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Rapid Purification of Human Bispecific Antibodies via Selective Modulation of Protein A Binding.
    Zwolak A; Leettola CN; Tam SH; Goulet DR; Derebe MG; Pardinas JR; Zheng S; Decker R; Emmell E; Chiu ML
    Sci Rep; 2017 Nov; 7(1):15521. PubMed ID: 29138497
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Progress in overcoming the chain association issue in bispecific heterodimeric IgG antibodies.
    Klein C; Sustmann C; Thomas M; Stubenrauch K; Croasdale R; Schanzer J; Brinkmann U; Kettenberger H; Regula JT; Schaefer W
    MAbs; 2012; 4(6):653-63. PubMed ID: 22925968
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Characterization of Bispecific Antibody Production in Cell Cultures by Unique Mixed Mode Size Exclusion Chromatography.
    Jiang H; Xu W; Liu R; Gupta B; Kilgore B; Du Z; Yang X
    Anal Chem; 2020 Jul; 92(13):9312-9321. PubMed ID: 32497423
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Controlled conductivity at low pH in Protein L chromatography enables separation of bispecific and other antibody formats by their binding valency.
    Chen C; Wakabayashi T; Muraoka M; Shu F; Wei Shan C; Chor Kun C; Tim Jang C; Soehano I; Shimizu Y; Igawa T; Nezu JI
    MAbs; 2019; 11(4):632-638. PubMed ID: 30898021
    [TBL] [Abstract][Full Text] [Related]  

  • 36. LC-MS characterization and purity assessment of a prototype bispecific antibody.
    Woods RJ; Xie MH; Von Kreudenstein TS; Ng GY; Dixit SB
    MAbs; 2013; 5(5):711-22. PubMed ID: 23884083
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Purification of antibody heteropolymers using hydrophobic interaction chromatography.
    Kostareva I; Hung F; Campbell C
    J Chromatogr A; 2008 Jan; 1177(2):254-64. PubMed ID: 17981289
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Transient and stable CHO expression, purification and characterization of novel hetero-dimeric bispecific IgG antibodies.
    Rajendra Y; Peery RB; Hougland MD; Barnard GC; Wu X; Fitchett JR; Bacica M; Demarest SJ
    Biotechnol Prog; 2017 Mar; 33(2):469-477. PubMed ID: 27977915
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Using bispecific antibodies in forced degradation studies to analyze the structure-function relationships of symmetrically and asymmetrically modified antibodies.
    Evans AR; Capaldi MT; Goparaju G; Colter D; Shi FF; Aubert S; Li LC; Mo J; Lewis MJ; Hu P; Alfonso P; Mehndiratta P
    MAbs; 2019; 11(6):1101-1112. PubMed ID: 31161859
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Removing a light-chain missing byproduct by MMC ImpRes mixed-mode chromatography under weak partitioning mode in purifying a WuXiBody-based bispecific antibody.
    Zhang T; Wan Y; Duan J; Li Y
    Protein Expr Purif; 2021 Oct; 186():105927. PubMed ID: 34111551
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.